Quick Takeaways
- Knight Therapeutics Inc filed SCHEDULE 13G for Synergy CHC Corp. Common Stock, par value $0.00001 per share (SNYR).
- Disclosed ownership: 17%.
- Date of event: 31 Dec 2024.
Knight Therapeutics Inc - 31 Dec 2024 SCHEDULE 13G Report for Synergy CHC Corp. Common Stock, par value $0.00001 per share (SNYR)
- Filing Manager
- Knight Therapeutics Inc
- Reporting Manager
- KNIGHT THERAPEUTICS INC.
- Symbol
- SNYR
- Shares outstanding
- 8,707,246 shares
- Disclosed Ownership
- 1,482,844 shares
- Ownership
- 17%
- Form type
- SCHEDULE 13G
- Filing time
- 20 Mar 2025, 16:01:13 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 13 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Knight Therapeutics Inc disclosed 17% ownership in Synergy CHC Corp. Common Stock, par value $0.00001 per share (SNYR) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 20 Mar 2025, 16:01.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| KNIGHT THERAPEUTICS INC. | 17% | 1,482,844 | 1,482,844 | 0 | /s/ Samira Sakhia | Samira Sakhia/President and Chief Executive Officer |